课题基金 / 基金详情

Elucidation of the steric bases of anticancer activities of interferons through a combined approach by X-ray crystal structure analyzes and protein engineering.

Elucidation of the steric bases of anticancer activities of interferons through a combined approach by X-ray crystal structure analyzes and protein engineering.
通过 X 射线晶体结构分析和蛋白质工程相结合的方法阐明干扰素抗癌活性的空间基础。
批准号:
04404088
负责人:
MITSUI Yukio
金额:
$14.08万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

MITSUI Yukio的其他基金

相似基金

相关文献

中文摘要
翻译
1) x射线衍射仪系统的搭建。本拨款购买的“衍射x射线束记录装置”,已完成使用成像板的二维x射线衍射仪的设置。2)电脑绘图系统的设置。本补助金所购买的“中央处理器升级系统”已成功纳入现有系统,大幅提升其效能。3)小鼠干扰素β晶体结构的细化使用上述系统1)和2),该结构已在2.15 A分辨率下细化到r因子为19.1%。广泛的修改是必要的A-Helix部分(EMBO杂志4,3193-3201 (1993);也提交给j.m l. biol。)4)预测各种I型干扰素的三维结构。对以下四种干扰素进行了结构预测:human-alpha,human-beta,牛和羊的tau's。针对I型干扰素的结构-活性关系研究的大量数据集被编译并基于已建立的三维结构进行系统评估(Pharmacology & Therapeutics, 58,93-132(1993))。5)人类α干扰素结晶的又一挑战。[参考译文]这次尝试和以前一样失败了,这表明不结晶性一定有一些根本的原因。使用动态光散射装置(例如)的更系统的方法是必要的。
英文摘要
1) Set-up of the X-ray diffractometer system.The "recording device for diffracted X-ray beam", whcih was purchased by the present grant, completed the set-up of the two-dimensional X-ray diffraactometer using Imaging Plates.2) Set-up of the computer graphics system.The "CPU-upgrading system" purchased by the present grant, was succesfully incorporated into the existing system extensively upgrading its performance.3) Refinement of the crystal structure of murine interferon-betaUsing the systems 1) and 2) above, the structure has been refined at 2.15 A resolution to an R-factor of 19.1%. Extensive modification was found necessary for the A-Helix portion (EMBO Journal 4,3193-3201 (1993) ; also submitted to J.Mol.Biol.)4) Prediction of the three-dimensional structures for various Type I interferons.Structure prediction was done for the following four interferons : human-alphaD,human-beta, bovine & ovine tau's. A huge data set of the structure-activity relationship studiesdirected for Type I interferons were compiled and systematically evaluated based on the established three-dimensional structure(Pharmacology & Therapeutics, 58,93-132 (1993)).5) Yet another challenege for the crystallization of human interferon-alpha.13EA10 : The attempt failed as before indicating that there must be some fundamental reason for non-crystallizability. More systematic approaches making use of a dynamic light scattering device (for example) would be necessary.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
野中孝昌、三井幸雄: "生体高分子のX線解析-最近の進歩-" 有機合成化学協会誌. 51. 551-562 (1993)
Takamasa Nonaka、Yukio Mitsui:“生物聚合物的 X 射线分析 - 最新进展 -”合成有机化学学会杂志 51. 551-562 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
野中孝昌、三井幸雄: "リボヌクレアーゼの立体構造と反応機構" 蛋白質・核酸・酵素『核酸化学の新展開』. (増刊号印刷中). (1995)
Takamasa Nonaka、Yukio Mitsui:“核糖核酸酶的三级结构和反应机制”蛋白质、核酸和酶“核酸科学的新进展”(印刷特刊)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 37 条
    Elucidation of the reaction mechanism of a PCB-degrading enzyme BphyC based on three-dimensional structural information.
    • 批准号:
      07458251
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.15万
    • 财政年份:
      1995
    • 负责人:
      MITSUI Yukio
    • 依托单位:
    New rapid method of protein crystal structure analyzes making use of protein engineering techniques
    • 批准号:
      07559006
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.03万
    • 财政年份:
      1995
    • 负责人:
      MITSUI Yukio
    • 依托单位:
    Development of a system for rapid protein structure
    • 批准号:
      03558017
    • 项目类别:
      Grant-in-Aid for Developmental Scientific Research (B)
    • 资助金额:
      $5.95万
    • 财政年份:
      1991
    • 负责人:
      MITSUI Yukio
    • 依托单位:
    Crystallographic Studies on Protease ー Substrate Interaction Using Genetically - Engineered Inhibitors.
    • 批准号:
      01480516
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $2.88万
    • 财政年份:
      1989
    • 负责人:
      MITSUI Yukio
    • 依托单位:
    海外基金